Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Understanding investment diversification is essential for any investor. Learn its importance and how it can benefit your portfolio.
28,657 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
MSFW has fallen sharply since its July 2025 launch, while weekly payouts crater from a peak of $0.97 to a recent $0.1...
JEPQ offers a near-9.5% yield by pairing Nasdaq-100 stocks with equity-linked notes. But the unsecured counterparty r...
A Goldman Sachs strategist warns that leverage is rising across retail investors, hedge funds, and leveraged ETFs, po...
As 2026 unfolds, lawmakers and the Social Security Administration weigh reforms that could reduce benefits for 66-yea...
iShares introduces a staking-enabled ETH fund that closely mirrors ETHA but adds monthly cash distributions, altering...
Oil climbs above triple digits as Strait of Hormuz tensions flare, pushing markets into a longer, volatile period. Th...
A margin increase on COMEX silver futures unleashed a swift selloff, sending prices skidding and testing key support....
A newly launched XRP ETF promises to deliver twice the daily moves of XRP, inviting traders to pursue a quick double ...
U.S. stocks wobbled Friday as the Russell 2000 slipped, but the small-cap rally remains a defining thread of 2026. In...
A single momentum-driven AI ETF is gaining attention as capex in AI hardware expands. The strategy aims to ride leade...
Susquehanna lifts Baidu's price target to $140 while maintaining a Neutral rating, citing AI Cloud strength but ongoi...